Document is current

Article History

Received: 16 February 2022

Accepted: 6 March 2022

First Online: 17 March 2022

Declarations

:

: Ethical and research governance approval was obtained from all relevant Ethics and Governance committees before commencement of the research. (Child and Adolescent health Service Ethics Committee, reference RGS3220 (for all sites) and Western Australian Aboriginal Health Ethics Committee reference HREC 920 (for all sites)). Written, informed consent will be obtained from all participants or the parents/guardians of minor participants before participation in interviews, focus groups, QoL tools or enrolment of children into the study. Parents/guardians may provide verbal consent if recruitment occurs via telephone for the nil-intervention group or if COVID-19 restrictions are implemented and such approval has been provided by all ethics committees. All data will be managed according to NHMRC research standards.

: Not applicable.

: Dr. Laird is funded by a Raine Fellowship, A/Prof Schultz is supported by an NHMRC/MRFF Investigator Grant [APP1193796]. Prof Chang is supported by an NHMRC Practitioner Fellowship [Grant 1058213] and a Queensland Children’s Hospital Foundation top-up [Grant 50286] and has received multiple NHMRC grants related to topics of cough and bronchiectasis including Centre of Research Excellence grants for lung disease [Grant 1040830] among Indigenous children and bronchiectasis [Grant 1170958]. All other authors have no competing interests.